Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets.
Mihaylova B, Wu R, Zhou J, Williams C, Schlackow I, Emberson J, Reith C, Keech A, Robson J, Parnell R, Armitage J, Gray A, Simes J, Baigent C. Mihaylova B, et al. Among authors: baigent c. Health Technol Assess. 2024 Dec;28(79):1-134. doi: 10.3310/KDAP7034. Health Technol Assess. 2024. PMID: 39644281 Free PMC article.
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).
Mihaylova B, Schlackow I, Herrington W, Lozano-Kühne J, Kent S, Emberson J, Reith C, Haynes R, Cass A, Craig J, Gray A, Collins R, Landray MJ, Baigent C; SHARP Collaborative Group. Mihaylova B, et al. Among authors: baigent c. Am J Kidney Dis. 2016 Apr;67(4):576-84. doi: 10.1053/j.ajkd.2015.09.020. Epub 2015 Nov 18. Am J Kidney Dis. 2016. PMID: 26597925 Free PMC article. Clinical Trial.
Interpretation of the evidence for the efficacy and safety of statin therapy.
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Collins R, et al. Among authors: baigent c. Lancet. 2016 Nov 19;388(10059):2532-2561. doi: 10.1016/S0140-6736(16)31357-5. Epub 2016 Sep 8. Lancet. 2016. PMID: 27616593 Free article. Review.
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.
Schlackow I, Kent S, Herrington W, Emberson J, Haynes R, Reith C, Collins R, Landray MJ, Gray A, Baigent C, Mihaylova B; SHARP Collaborative Group. Schlackow I, et al. Among authors: baigent c. Kidney Int. 2019 Jul;96(1):170-179. doi: 10.1016/j.kint.2019.01.028. Epub 2019 Mar 12. Kidney Int. 2019. PMID: 31005271 Free PMC article. Clinical Trial.
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model.
Wu R, Williams C, Zhou J, Schlackow I, Emberson J, Reith C, Keech A, Robson J, Armitage J, Gray A, Simes J, Baigent C, Mihaylova B; CTT Collaboration secretariat CTT Collaboration trialists: A to Z trial (phase Z) AFCAPS/TEXCAPS (AirForce/Texas Coronary Atherosclerosis Prevention Study)ALERT (Assessment of Lescol in Renal Transplantation)ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)ALLIANCE (Aggressive Lipid-Lowering Initiation Abates New Cardiac Events)ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial)ASPEN (Atorvastatin Study for the Prevention of Coronary Heart Disease Endpoints in Non-Insulin Dependent Diabetes Mellitus)AURORA (A study to evaluate the Use of Rosuvastatin in subjects On Regular haemodialysis: an Assessment of survival and cardiovascular events)CARDS (Collaborative Atorvastatin Diabetes Study)CARE (Cholesterol And Recurrent Events Study)CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)4D (Die Deutsche Diabetes Dialyse Studie)GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico) Heart Failure and Prevention trialsHOPE-3HPS (Heart Protection Study)IDEAL (Incremental Decrea… See abstract for full author list ➔ Wu R, et al. Among authors: baigent c. Br J Gen Pract. 2024 Feb 29;74(740):e189-e198. doi: 10.3399/BJGP.2023.0198. Print 2024 Mar. Br J Gen Pract. 2024. PMID: 38373851 Free PMC article.
Misrepresentation of statin safety evidence.
Armitage J, Baigent C, Collins R. Armitage J, et al. Among authors: baigent c. Lancet. 2014 Oct 4;384(9950):1263-4. doi: 10.1016/S0140-6736(14)61765-7. Lancet. 2014. PMID: 25283569 No abstract available.
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.
Cholesterol Treatment Trialists' (CTT) Collaboration; Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B, Jardine AG, Wanner C, Holdaas H, Fulcher J, Haynes R, Landray MJ, Keech A, Simes J, Collins R, Baigent C. Cholesterol Treatment Trialists' (CTT) Collaboration, et al. Among authors: baigent c. Lancet Diabetes Endocrinol. 2016 Oct;4(10):829-39. doi: 10.1016/S2213-8587(16)30156-5. Epub 2016 Jul 29. Lancet Diabetes Endocrinol. 2016. PMID: 27477773 Free article.
Lessons from the controversy over statins - Authors' reply.
Armitage J, Baigent C, Collins R. Armitage J, et al. Among authors: baigent c. Lancet. 2016 Nov 5;388(10057):2237-2238. doi: 10.1016/S0140-6736(16)32075-X. Lancet. 2016. PMID: 27825506 No abstract available.
Are statins useful in patients with advanced chronic kidney disease? - Authors' reply.
Herrington WG, Emberson J, Mihaylova B, Collins R, Baigent C; Cholesterol Treatment Trialists' Collaboration. Herrington WG, et al. Among authors: baigent c. Lancet Diabetes Endocrinol. 2016 Dec;4(12):971-972. doi: 10.1016/S2213-8587(16)30266-2. Lancet Diabetes Endocrinol. 2016. PMID: 27886746 No abstract available.
299 results